Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/7332
Title: Ibuprofen and diclofenac differentially affect cell viability, apoptosis and morphology changes of human cholangiocarcinoma cell lines
Authors: Leksomboon, Ratana
Kumpangnil, Kamonrot
Keywords: Apoptosis
Cholangiocarcinoma
Diclofenac
Ibuprofen
Morphological changes
Issue Date: 2022
Publisher: Journal of Taibah University Medical Sciences
Series/Report no.: Original Article;869-879
Abstract: Objectives: Cholangiocarcinoma is a malignant biliary epithelial duct neoplasm caused by chronic inflammation after liver fluke infection. It is amajor public health concern in the Greater Mekong sub-region in northeast Thailand. Herein, the effects of the non-steroidal anti-inflammatory drugs (NSAIDs) ibuprofen and diclofenac on the cell proliferation activity of the human cholangiocarcinoma cell lines KKU-M139 and KKU-213B were studied. Methods: Cell viability was assessed with MTT assays. Inverted phase-contrast light microscopy, scanning electron microscopy and transmission electron microscopy were used to investigate the cells’ morphological alterations. Caspase 3/7 and Annexin V/PI were detected with a multimode microplate reader. Results: Ibuprofen and diclofenac decreased viability in both cell lines, and ibuprofen-treated cells exhibited reversible cell injury. In both KKU-M139 and KKU- 213B cell lines, the diclofenac-treated cells had the greatest injury. The cells exhibited features of irreversible cell injury. In addition, caspase 3/7 and Annexin V/PI detection revealed early cell apoptotic characteristics. Conclusion: These findings suggest that NSAIDs may potentially suppress cell viability. Ibuprofen and diclofenac both induced morphological changes and apoptosis.
URI: http://localhost:8080/xmlui/handle/123456789/7332
ISSN: 1658-3612
Appears in Collections:Vol 17 No 5 (2022)

Files in This Item:
File Description SizeFormat 
869-879.pdf869-8794.6 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.